441 related articles for article (PubMed ID: 24225075)
1. Are anti-proteinase-3 ANCA a useful marker of granulomatosis with polyangiitis (Wegener's) relapses? Results of a retrospective study on 126 patients.
Thai LH; Charles P; Resche-Rigon M; Desseaux K; Guillevin L
Autoimmun Rev; 2014 Mar; 13(3):313-8. PubMed ID: 24225075
[TBL] [Abstract][Full Text] [Related]
2. Changes in proteinase 3 anti-neutrophil cytoplasm autoantibody levels in early systemic granulomatosis with polyangiitis (Wegener's) may reflect treatment rather than disease activity.
Rasmussen N; Salmela A; Ekstrand A; de Groot K; Gregorini G; Cohen Tervaert JW; Gross WL; Wiik A; Jayne DR;
Clin Exp Rheumatol; 2013; 31(1 Suppl 75):S38-44. PubMed ID: 23380137
[TBL] [Abstract][Full Text] [Related]
3. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive and ANCA-Negative Patients With Granulomatosis With Polyangiitis (Wegener's): Distinct Patient Subsets.
Miloslavsky EM; Lu N; Unizony S; Choi HK; Merkel PA; Seo P; Spiera R; Langford CA; Hoffman GS; Kallenberg CG; St Clair EW; Tchao NK; Fervenza F; Monach PA; Specks U; Stone JH
Arthritis Rheumatol; 2016 Dec; 68(12):2945-2952. PubMed ID: 27428559
[TBL] [Abstract][Full Text] [Related]
4. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive Granulomatosis With Polyangiitis (Wegener's) Is a Clinically Distinct Subset of ANCA-Associated Vasculitis: A Retrospective Analysis of 315 Patients From a German Vasculitis Referral Center.
Schirmer JH; Wright MN; Herrmann K; Laudien M; Nölle B; Reinhold-Keller E; Bremer JP; Moosig F; Holle JU
Arthritis Rheumatol; 2016 Dec; 68(12):2953-2963. PubMed ID: 27333332
[TBL] [Abstract][Full Text] [Related]
5. Clinical and prognostic features of Korean patients with MPO-ANCA, PR3-ANCA and ANCA-negative vasculitis.
Yoo J; Kim HJ; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
Clin Exp Rheumatol; 2017; 35 Suppl 103(1):111-118. PubMed ID: 28339364
[TBL] [Abstract][Full Text] [Related]
6. Prospective monitoring of in vitro produced PR3-ANCA does not improve relapse prediction in granulomatosis with polyangiitis.
Land J; Abdulahad WH; Arends S; Sanders JF; Stegeman CA; Heeringa P; Rutgers A
PLoS One; 2017; 12(8):e0182549. PubMed ID: 28771641
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of interleukin-32 and interleukin-6 in granulomatosis with polyangiitis and microscopic polyangiitis: association with clinical and biochemical findings.
Krajewska Wojciechowska J; Kościelska-Kasprzak K; Krajewski W; Morawski K
Eur Cytokine Netw; 2019 Dec; 30(4):151-159. PubMed ID: 32096477
[TBL] [Abstract][Full Text] [Related]
8. Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosis.
Finkielman JD; Merkel PA; Schroeder D; Hoffman GS; Spiera R; St Clair EW; Davis JC; McCune WJ; Lears AK; Ytterberg SR; Hummel AM; Viss MA; Peikert T; Stone JH; Specks U;
Ann Intern Med; 2007 Nov; 147(9):611-9. PubMed ID: 17975183
[TBL] [Abstract][Full Text] [Related]
9. There is no benefit in routinely monitoring ANCA titres in patients with granulomatosis with polyangiitis.
Verstockt B; Bossuyt X; Vanderschueren S; Blockmans D
Clin Exp Rheumatol; 2015; 33(2 Suppl 89):S-72-6. PubMed ID: 26016753
[TBL] [Abstract][Full Text] [Related]
10. The avidity of PR3-ANCA in patients with granulomatosis with polyangiitis during follow-up.
Kemna MJ; Schlumberger W; van Paassen P; Dähnrich C; Damoiseaux JG; Cohen Tervaert JW
Clin Exp Immunol; 2016 Aug; 185(2):141-7. PubMed ID: 27009928
[TBL] [Abstract][Full Text] [Related]
11. Performance evaluation of three assays for the detection of PR3-ANCA in granulomatosis with polyangiitis in daily practice.
Noel N; André C; Bengoufa D; Dehoulle C; Mahler M; Limal N; Godeau B; Hüe S
Autoimmun Rev; 2013 Oct; 12(12):1118-22. PubMed ID: 23800447
[TBL] [Abstract][Full Text] [Related]
12. Image analysis: a novel approach for the quantification of antineutrophil cytoplasmic antibody levels in patients with Wegener's granulomatosis.
Boomsma MM; Damoiseaux JG; Stegeman CA; Kallenberg CG; Patnaik M; Peter JB; Tervaert JW
J Immunol Methods; 2003 Mar; 274(1-2):27-35. PubMed ID: 12609530
[TBL] [Abstract][Full Text] [Related]
13. 4C3 Human Monoclonal Antibody: A Proof of Concept for Non-pathogenic Proteinase 3 Anti-neutrophil Cytoplasmic Antibodies in Granulomatosis With Polyangiitis.
Granel J; Lemoine R; Morello E; Gallais Y; Mariot J; Drapeau M; Musnier A; Poupon A; Pugnière M; Seren S; Nouar D; Gouilleux-Gruart V; Watier H; Korkmaz B; Hoarau C
Front Immunol; 2020; 11():573040. PubMed ID: 33101296
[TBL] [Abstract][Full Text] [Related]
14. Interference of PR3-ANCA with the enzymatic activity of PR3: differences in patients during active disease or remission of Wegener's granulomatosis.
van der Geld YM; Tool AT; Videler J; de Haas M; Tervaert JW; Stegeman CA; Limburg PC; Kallenberg CG; Roos D
Clin Exp Immunol; 2002 Sep; 129(3):562-70. PubMed ID: 12197900
[TBL] [Abstract][Full Text] [Related]
15. Comparative investigation of respiratory tract involvement in granulomatosis with polyangiitis between PR3-ANCA positive and MPO-ANCA positive cases: a retrospective cohort study.
Ikeda S; Arita M; Misaki K; Kashiwagi Y; Ito Y; Yamada H; Hotta M; Nishiyama A; Ito A; Noyama M; Koyama T; Notohara K; Ishida T
BMC Pulm Med; 2015 Jul; 15():78. PubMed ID: 26223225
[TBL] [Abstract][Full Text] [Related]
16. Pathogenicity of Proteinase 3-Anti-Neutrophil Cytoplasmic Antibody in Granulomatosis With Polyangiitis: Implications as Biomarker and Future Therapies.
Granel J; Korkmaz B; Nouar D; Weiss SAI; Jenne DE; Lemoine R; Hoarau C
Front Immunol; 2021; 12():571933. PubMed ID: 33679731
[TBL] [Abstract][Full Text] [Related]
17. Relevance of classic anti-neutrophil cytoplasmic autoantibody (C-ANCA)-mediated inhibition of proteinase 3-alpha 1-antitrypsin complexation to disease activity in Wegener's granulomatosis.
Dolman KM; Stegeman CA; van de Wiel BA; Hack CE; von dem Borne AE; Kallenberg CG; Goldschmeding R
Clin Exp Immunol; 1993 Sep; 93(3):405-10. PubMed ID: 8370167
[TBL] [Abstract][Full Text] [Related]
18. Glycosylation of proteinase 3 (PR3) is not required for its reactivity with antineutrophil cytoplasmic antibodies (ANCA) in Wegener's granulomatosis.
Finkielman JD; Merkel PA; Schroeder D; Hoffman GS; Spiera R; St Clair EW; Davis JC; McCune WJ; Lears A; Ytterberg SR; Hummel AM; Viss MA; Peikert T; Stone JH; Specks U;
Clin Exp Rheumatol; 2009; 27(1 Suppl 52):S45-52. PubMed ID: 19646346
[TBL] [Abstract][Full Text] [Related]
19. Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study.
Boomsma MM; Stegeman CA; van der Leij MJ; Oost W; Hermans J; Kallenberg CG; Limburg PC; Tervaert JW
Arthritis Rheum; 2000 Sep; 43(9):2025-33. PubMed ID: 11014352
[TBL] [Abstract][Full Text] [Related]
20. Advances in pathogenesis and treatment of ANCA-associated vasculitis.
Kallenberg CG
Discov Med; 2014 Oct; 18(99):195-201. PubMed ID: 25336033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
